WILLIAM C. FREDERICKS holds a B.A. (with high honors) from
Swarthmore College (Pa.), an M. Litt. in International Relations from Oxford
University (England), and a J.D. from Columbia University Law School
(N.Y.).[nbsp] At Columbia, Mr. Fredericks was also a three-time Harlan Fiske
Stone Scholar, a Columbia University International Fellow, and the winner of
the law school’s Beck Prize (property law), Toppan Prize (advanced
constitutional law), Greenbaum Prize (written advocacy), and Dewey Prize (oral
After clerking for the Hon. Robert S. Gawthrop III (E.D.
Pa.), Mr. Fredericks spent seven years practicing securities and complex
commercial litigation at Simpson Thacher [&] Bartlett LLP and Willkie Farr
[&] Gallagher LLP in New York before moving to the plaintiffs’ side of the
bar in 1996.[nbsp] Since 1996, Mr. Fredericks has represented investors as a
lead or co-lead plaintiff in dozens of securities class actions, including In
re Wachovia Preferred Securities and Bond/Notes Litig., (S.D.N.Y.) (total
settlements of $627 million, reflecting the largest recovery ever in a pure
Securities Act case not involving any parallel government fraud claims); In
re Rite Aid Securities Litig. (E.D. Pa.) (total settlements of $323
million, including the then-second largest securities fraud settlement ever
against a Big Four accounting firm); In re Sears Roebuck [&] Co. Sec.
Litig. (N.D. Ill.) ($215 million settlement, representing the largest
§10(b) class action recovery ever not involving either a financial restatement
or parallel government fraud claims); In re State Street ERISA Litig.
(S.D.N.Y.) (one of the largest ERISA class settlements to date) and Irvine
v. Imclone Systems, Inc. (S.D.N.Y.) ($75 million settlement).[nbsp] Mr.
Fredericks also played a lead role on the team that obtained a rare 9-0
decision for securities fraud plaintiffs in the U.S. Supreme Court in Merck
[&] Co., Inc. v. Reynolds, and has coauthored several amicus briefs in
other Supreme Court cases involving securities issues (including the recent
Halliburton and Amgen cases).
Mr. Fredericks is currently recognized in the 2012-13
edition of “America’s Best Lawyers” in the field of commercial litigation, and
is a frequent panelist on securities litigation programs sponsored by various
organizations, including the Practising Law Institute (PLI) and the American
Law Institute/American Bar Association (ALI/ABA).[nbsp] He is also a member of
the New York City Bar Association (former chair, Committee on Military Affairs
and Justice), the Federal Bar Council and the American Bar Association.